fucose has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamada, Y; Minehira, T; Miyoshi, E; Nakayama, K; Sobajima, T; Takamatsu, S; Terao, N | 1 |
| Gupta, N; Jangid, AK; Kulhari, H; Pooja, D; Singh, M | 1 |
2 other study(ies) available for fucose and gemcitabine
| Article | Year |
|---|---|
Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes.
Topics: Antimetabolites, Antineoplastic; CD24 Antigen; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fucose; Fucosyltransferases; Galactoside 2-alpha-L-fucosyltransferase; Gemcitabine; Glycosylation; Humans; Hyaluronan Receptors; Neoplastic Stem Cells; Pancreatic Neoplasms; RNA Interference; Spheroids, Cellular; Transfection | 2015 |
Designing Two-Dimensional Nanosheets for Improving Drug Delivery to Fucose-Receptor-Overexpressing Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Deoxycytidine; Drug Liberation; Fucose; Gemcitabine; Graphite; Humans; Hydrogen-Ion Concentration; Molecular Targeted Therapy; Nanostructures; Receptors, Cell Surface | 2018 |